WHO ICTRP trial
Therapeutic effects of N-AcetylCysteine in Bipolar Mania as assessed by Serum…
CTRI/2023/08/056207 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/08/056207 |
|---|---|
| Public title | Therapeutic effects of N-AcetylCysteine in Bipolar Mania as assessed by Serum Glutathione levels |
| Scientific title | N-AcetylCysteine as an adjunctive therapy in Bipolar Mania and its correlation with Serum Glutathione levels : A Randomised Open Label Trial - NIL |
| Primary sponsor | Central Institute of Psychiatry |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: F312- Bipolar disorder, current episodemanic severe with psychotic features |
| Interventions | Intervention1: N-AcetylCysteine in Bipolar Mania with psychotic symptoms: N-AcetylCysteine will be given for total duration of 6 weeks, 2 g/day will be given for first 4 weeks followed by 4 g/day for next 2 weeks Control Intervention1: NIL… |
| Registration date | Jul 8, 2023 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: